Smith Sandford D's Form 4 filing
Cytokinetics Inc (CYTK) · filed Nov 19, 2021
- Accession no.
- 0001061983-21-000261
- Filed
- Nov 19, 2021
- Trade date
- Nov 19, 2021
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.20M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Smith Sandford DCIK 0001243004 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 19, 2021 | Common Stock | MOption exerciseAcquired | +5,000 | $9.45 | +$47,250 | 11,765 | Direct | |
| Nov 19, 2021 | Common Stock | SSaleDisposed | −5,000 | $41.21 | −$206,050 | 6,765 | Direct | |
| Nov 19, 2021 | Common Stock | MOption exerciseAcquired | +20,000 | $14.25 | +$285,000 | 26,765 | Direct | |
| Nov 19, 2021 | Common Stock | SSaleDisposed | −20,000 | $41.21 | −$824,200 | 6,765 | Direct | |
| Nov 19, 2021 | Common Stock | MOption exerciseAcquired | +4,032 | $12.40 | +$49,996.8 | 10,797 | Direct | |
| Nov 19, 2021 | Common Stock | SSaleDisposed | −4,032 | $41.21 | −$166,158.72 | 6,765 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 19, 2021 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 0 | Direct | |
| Nov 19, 2021 | Common Stock | MOption exerciseDisposed | −4,032 | $0.00 | $0 | 0 | Direct | |
| Nov 19, 2021 | Common Stock | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.